[ad_1]
MANILA, Philippines – President Rodrigo Duterte on Monday dismissed senators who are urging the government to prioritize purchasing COVID-19 vaccines developed by Pfizer-BioNTech after reports that some elderly and very frail people in Norway have died after receiving the injections.
“Do the senators want Pfizer? B In Norway, 25 people died after receiving the Pfizer vaccine. You want it? We will order for you. That is what he wants as it is reported repeatedly in the Inquirer articles, ”Duterte said, speaking in part in Filipino during his weekly taped briefing.
It is not clear if there is a direct link between the deaths in Norway and the vaccine.
Due to the high efficacy rate of the Pfizer vaccine, several senators have urged the government to prioritize negotiations with the pharmaceutical giant.
Pfizer has already obtained an Emergency Use Authorization (USA) in the Philippines for its vaccine, which is expected to be used through COVAX facilities.
Health authorities said they will wait for Pfizer’s report on the deaths reported in Norway.
The Philippines has so far secured 25 million doses of coronavirus vaccines from China’s Sinovac BioTech, 17 million doses from British pharmaceutical company AstraZeneca through private sector and local government units, and 30 million doses of the Covovax vaccine from Indian manufacture.
RELATED STORY
Norway warns of caution in the use of Pfizer vaccine for the most fragile
[atm]
For more news on the new coronavirus, click here.
What you need to know about the coronavirus.
For more information on COVID-19, call the DOH hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare leaders and still accepts cash donations to be deposited into the Banco de Oro (BDO) checking account # 007960018860 or donate through PayMaya using this link .
Read next
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer and more than 70 other titles, share up to 5 gadgets, listen to the news, download from 4am and share articles on social media. Call 896 6000.
For comments, complaints or inquiries, please contact us.
[ad_2]